| 000 | 01785pam a2200421 a 4500 | ||
|---|---|---|---|
| 001 | 614533 | ||
| 003 | OSt | ||
| 005 | 20211116163123.0 | ||
| 008 | 920313s1992 nyua b 001 0 eng c | ||
| 010 | _a 92011898 | ||
| 020 | _a0881679232 | ||
| 040 |
_aDNLM/DLC _cDLC _dDLC |
||
| 050 | 0 | 0 |
_aRM315.A4 vol. 47 _aQP563.G32 |
| 082 | 0 | 0 |
_a615/.78 s _a615/.78 _220 |
| 245 | 0 | 0 |
_aGABAergic synaptic transmission: molecular, pharmacological, and clinical aspects. / _cVolume editors, Giovanni Biggio, Alessandra Concas, Erminio Costa. |
| 260 |
_aNew York: _bRaven Press, _c1992. |
||
| 300 |
_axxiv, 469 p. : _bill. ; _c25 cm. |
||
| 440 | 0 |
_aAdvances in biochemical psychopharmacology ; _vv. 47 |
|
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | _aContents: Neurosteroids: an overview -- Molecular biology and molecular pharmacology -- allosteric modulators: he neurosteroids -- GABA/Benzodiazepine receptor subclasses -- Ethanol and general -- Benzodiazepines vs. non-benzodiazepine GABAergic drugs -- | ||
| 650 | 0 |
_aGABA _xReceptors. |
|
| 650 | 0 | _aNeural transmission. | |
| 650 | 0 | _aMolecular pharmacology. | |
| 650 | 0 |
_aBenzodiazepines _xReceptors. |
|
| 650 | 0 |
_aSteroids _xPhysiological effect. |
|
| 650 | 0 |
_aAlcohol _xPhysiological effect. |
|
| 650 | 0 |
_aAnesthetics _xPhysiological effect. |
|
| 650 | 2 |
_aNeural Transmission _xcongresses. |
|
| 650 | 2 |
_aReceptors, GABA-Benzodiazepine _xgenetics _xcongresses. |
|
| 650 | 2 |
_aReceptors, GABA-Benzodiazepine _xphysiology _xcongresses. |
|
| 650 | 0 |
_aReceptors, Synaptic _xphysiology _xcongresses. |
|
| 700 | 1 | _aBiggio, Giovanni. | |
| 700 | 1 | _aConcas, Alessandra. | |
| 700 | 1 | _aCosta, Erminio. | |
| 906 |
_a7 _bcbc _corignew _d1 _eocip _f19 _gy-gencatlg |
||
| 942 |
_2lcc _cBK |
||
| 999 |
_c8018 _d15518 |
||